Douglas H. Descalzi

Douglas Descalzi joined Omnicell in November 2014. Prior to Omnicell, Mr. Descalzi held a variety of leadership positions with Bayer HealthCare, formerly MEDRAD, Inc. He founded the molecular imaging device business at Bayer and served as the Head of Research and Development for Computed Tomography, MEDRAD’s largest business unit. Mr. Descalzi started his career at GE and has co-founded several technology-based startups. He holds a BS in Aerospace Engineering from the University of Notre Dame, an MS in Systems Engineering from Virginia Tech, and an MBA from the University of Virginia.